Peripheral Metabolism of Lipoprotein-amyloid Beta as a Risk Factor for Diabetes-induced Alzheimer's Disease and the Therapeutic Effects of Probucol and its Analogue
| dc.contributor.author | Sharif, Arazu | |
| dc.contributor.supervisor | Ryu Takechi | en_US |
| dc.contributor.supervisor | Virginie Lam | en_US |
| dc.contributor.supervisor | John Mamo | en_US |
| dc.date.accessioned | 2025-05-09T01:40:20Z | |
| dc.date.available | 2025-05-09T01:40:20Z | |
| dc.date.issued | 2024 | en_US |
| dc.identifier.uri | http://hdl.handle.net/20.500.11937/97705 | |
| dc.description.abstract |
Peripheral Metabolism of Lipoprotein-amyloid Beta as a Risk Factor for Diabetes-induced Alzheimer's Disease and the Therapeutic Effects of Probucol and its Analogue | en_US |
| dc.publisher | Curtin University | en_US |
| dc.title | Peripheral Metabolism of Lipoprotein-amyloid Beta as a Risk Factor for Diabetes-induced Alzheimer's Disease and the Therapeutic Effects of Probucol and its Analogue | en_US |
| dc.type | Thesis | en_US |
| dcterms.educationLevel | PhD | en_US |
| curtin.department | Curtin Medical School | en_US |
| curtin.accessStatus | Fulltext not available | en_US |
| curtin.faculty | Health Sciences | en_US |
| curtin.contributor.orcid | Sharif, Arazu [0000-0002-5543-678X] | en_US |
| dc.date.embargoEnd | 2027-05-05 |